Pat Soon-Shiong, Chairman of Chan Soon-Shiong Family Foundation, Executive Chairman at ImmunityBio, and Executive Chairman of the Los Angeles Times, shared a post on X:
“So the Thymus produces T cells. IL-15 is a T cell growth factor.
When the Thymus is removed, there is a 2x higher chance of dying earlier of all causes according to this report.
These findings are consistent with the JAMA paper that shows when ALC is less than 1,500 (low T cells) longevity is decreased with increased mortality risk from all causes.
The data is consistent: IL-15 is a T cell growth factor and they called T cells because of the T in Thymus. And IL-15 was ranked #1 by NCI and FDA to “cure” cancer as far back as 2007.
Now this report links the Thymus (which produces T cells) to longevity – consistent with the JAMA report that 52 million Americans suffer from low T cells, called lymphopenia. IL-15 to treat cancer, enable longevity and to overcome sepsis – Immunotherapy 2.0. Stay tuned.
Are the dots connecting that ALC matters?
JAMA Zidar 2019: “Association of Lymphopenia With Risk of Mortality Among Adults in the US General Population”
‘The body’s most mysterious organ may play a key role in longevity and cancer. What to know about the incredible shrinking thymus.’ ”
Title: Association of Lymphopenia With Risk of Mortality Among Adults in the US General Population
Authors: David Zidar, Sadeer Al-Kindi, Yongmei Liu, Nikolas Krieger, Adam Perzynski, Michael Osnard, Christopher Nmai, Donald Anthony, Michael Lederman, Michael Freeman, Robert Bonomo, Daniel Simon, Jarrod Dalton
Read the Full Article.
Other articles featuring Pat Soon-Shiong on OncoDaily.